At Human Genetic Signatures, we design, develop and market a novel molecular diagnostics assay technology called 3base™ that simplifies the genomes of microbial targets, improving patient testing.
Our 3base™ technology is adaptable to a broad menu of tests, the results of which assist in detecting the presence of viruses and bacteria and in the future, monitoring disease progression and guiding therapy.
3base™ is cost effective, platform-flexible, highly sensitive and designed to significantly improve the ability to clinically screen for highly variant subtypes compared to existing technologies.